Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs

NCT07589322 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Obesity and Metabolic Syndrome

Interventions

DRUG: Tirzepatide with lifestyle modification
DRUG: Semaglutide with lifestyle modification

Sponsor

Tri-Service General Hospital

Collaborators

[object Object]